By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Architects are already looking beyond COVID-19 to imagine the office of 2025 and beyond — an office that will keep us safe on the job, whatever pandemic virus strikes next.
Journalist Bob Woodward has faced some criticism for not promptly sharing with the public what the president told him about the coronavirus in a series of interviews earlier this year.
Big Ten Conference university leaders were presented a comprehensive plan Sunday to conduct a fall football season, but a final decision is still to come.
The race for Sen. Joni Ernst's seat could help determine control of the Senate. At a recent campaign event, the GOP lawmaker echoed a debunked conspiracy theory about the pandemic's death toll.
The pandemic has sparked a sustained, unprecedented tidal wave of home and backyard projects. The demand outstrips the supply of materials and labor to do the work, leaving homeowners to get creative.
Minnesota’s COVID-19 outbreak appears to have recovered from a modest spike in late August, according to the latest data released by health officials Sunday. The numbers of daily new cases and new hospitalizations have trended downward from the peak last month.
After talking with experts for a story last week, we asked readers for their advice on how to help older people feel safe and comfortable — and happy — during the pandemic. Here are their suggestions.
More than 100 people rallied outside the Minnesota Capitol in St. Paul on Saturday in support of President Trump, and against statewide pandemic policies they say are infringing on personal freedoms and damaging the economy.
Drugmaker AstraZeneca announced Saturday that its COVID-19 vaccine studies have resumed in the United Kingdom, though not yet in the United States. The vaccine trials had been placed on hold after a U.K. participant in one of the studies developed a neurological illness.
Coronavirus infections in the Dakotas are growing faster than anywhere else in the nation, fueling impassioned debates over masks and personal freedom after months in which the two states avoided the worst of the pandemic.